Masaaki Takeda is a prominent inventor based in Urawa, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that inhibit gastric acid secretion. With a total of 7 patents to his name, Takeda's work has had a considerable impact on medical science.

Latest Patents

Among his latest patents are innovative compounds such as antisecretory imidazole amidine compounds and guanidinothiazole compounds. The antisecretory imidazole amidine compounds are characterized by a complex formula that includes various heterocyclic groups and pharmacologically acceptable acid addition salts. These compounds are particularly useful as gastric acid secretion inhibitors. Similarly, the guanidinothiazole compounds also serve as gastric acid secretion inhibitors and are defined by a specific general formula that includes various functional groups.

Career Highlights

Masaaki Takeda has been associated with Yamanouchi Pharmaceutical Company Ltd., where he has contributed to groundbreaking research and development in the pharmaceutical industry. His work has focused on creating effective medical compositions that address gastric acid-related conditions.

Collaborations

Throughout his career, Takeda has collaborated with notable colleagues such as Yasufumi Hirata and Isao Yanagisawa. These collaborations have further enhanced the quality and scope of his research.

Conclusion

Masaaki Takeda's innovative work in the field of gastric acid secretion inhibitors has established him as a key figure in pharmaceutical research. His contributions continue to influence the development of effective medical treatments.

Profile summary based on public USPTO records.

Please report any incorrect information to [email protected]